While the BBGD phenotype is thought to be secondary to a loss-of-function mutation, the Japanese boy encephalopathy may be due to a toxic gain-of-function secondary to the SLC19A3 mutation [9]. The gene discussed is SLC19A3; the disease is biotin-responsive basal ganglia disease.